Balboa Wealth Partners »

Halozyme Therapeutics shares owned by Balboa Wealth Partners

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Balboa Wealth Partners from 13F filings

Historical chart of Balboa Wealth Partners investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Balboa Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Balboa Wealth Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $235k 5.8k 40.68

More positions owned by Balboa Wealth Partners

NVIDIA Corporation (NVDA)
Tesla Call Call Option (Principal)
Microsoft Corporation (MSFT)
Advanced Micro Devices (AMD)
Amazon (AMZN)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Spdr Gold Tr Gold Shs (GLD)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Asml Holding N V N Y Registry Shs (ASML)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Balboa Wealth Partners

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
Snyder Capital Management
Artisan Partners Limited Partnership
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
TD Asset Management
Jennifer Ranahan
Arrowpoint Asset Management
Northern Trust
Thrivent Financial for Lutherans
Bank of America Corporation
Dimensional Fund Advisors
Charles Schwab Investment Management

View all funds holding Halozyme Therapeutics